The approval is based on findings from a phase 3 study which demonstrated the drug’s superiority over chemotherapy.
The Food and Drug Administration (FDA) has approved a new maintenance dosing schedule for Leqembi, a monoclonal antibody ...
The antibody drug conjugate was approved for patients with unresectable or metastatic HER2-low or -ultralow breast cancer ...
A monthly 10 mg/mL maintenance dose of Leqembi had the same effects on mild Alzheimer’s symptoms as biweekly dose, research ...
Joel Stanley, the founder and former CEO of Charlotte’s Web, is leading an effort to achieve approval from the FDA for a ...
The FDA has approved GRAFAPEXâ„¢ and fludarabine as a preparative regimen in acute myeloid leukemia or myelodysplastic syndrome ...